Cargando…
Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study
BACKGROUND AND AIMS: Thrombosis is a major driver of adverse outcome and mortality in patients with Coronavirus disease 2019 (COVID-19). Hypercoagulability may be related to the cytokine storm associated with COVID-19, which is mainly driven by interleukin (IL)-6. Plasma lipoprotein(a) [Lp(a)] level...
Autores principales: | Nurmohamed, Nick S., Collard, Didier, Reeskamp, Laurens F., Kaiser, Yannick, Kroon, Jeffrey, Tromp, Tycho R., van den Born, Bert-Jan H., Coppens, Michiel, Vlaar, Alexander P.J., Beudel, Martijn, van de Beek, Diederik, van Es, Nick, Moriarty, Patrick M., Tsimikas, Sotirios, Stroes, Erik S.G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690577/ https://www.ncbi.nlm.nih.gov/pubmed/34995986 http://dx.doi.org/10.1016/j.atherosclerosis.2021.12.008 |
Ejemplares similares
-
Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort study
por: Collard, Didier, et al.
Publicado: (2021) -
Considerations for routinely testing for high lipoprotein(a)
por: Nurmohamed, Nick S, et al.
Publicado: (2023) -
From evidence to practice: development of web-based Dutch lipid reference values
por: Nurmohamed, N. S., et al.
Publicado: (2021) -
Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis
por: Moriarty, Patrick M., et al.
Publicado: (2020) -
Single-Dose Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
por: Beudel, Martijn, et al.
Publicado: (2021)